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Abstract - In malaria, blood concentrations of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) 
and interleukin (IL)-6, are increased. In a study which included 34 patients, TNF-α and IL-6 were examined in two phases, 
immediately after the admission of patients, and at the end of antimalarial therapy, when the parasitemia was negative. The 
results show a significant increase of TNF-α and IL-6 in the first phase, before the effects of antimalarial therapy. A very 
strong correlation between TNF-α and IL-6 is also confirmed, which suggests their coordinated production. Increased 
TNF-α values were correlated with an older age, the level of parasitemia, the number of platelets and leukocytes, elevated 
values of procalcitonin, D-dimer and lactate dehydrogenasе, and lower values of serum iron and antithrombin. Increased 
values of IL-6 were correlated with the level of parasitemia, the number of platelets and leukocytes, and elevated values of 
D-dimer and lactates.
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INTRODUCTION
Patients with malaria, especially in severe forms, 
have an increased concentration of proinflamma-
tory cytokines, of which TNF-α has been the most 
often examined (Chen et al., 2000). The increasing 
concentration  of  TNF-α  in  malaria  was  first  re-
corded in 1986 (Scuderi et al., 1986). Kwiatkowski 
et  al.  (1989)  demonstrated  a  significant  increase 
in TNF-α levels in children with malaria in Gam-
bia. In malaria, as well as in other systemic infec-
tions and diseases, the release of proinflammatory 
cytokines  produces  a  systemic  inflammatory  re-
sponse. Previous research related to sepsis and ma-
laria has shown that TNF-α, the prototype of proin-
flammatory cytokines, increased in both diseases, 
causing hyperlactatemia. It is well known that in-
creased regulation of proinflammatory cytokines in 
the process of adhesion to endothelial cells attracts 
circulating blood elements on the inner wall of the 
vessel (Sarangi et al., 2011). In many diseases, in-
cluding malaria, this includes activated leukocytes 
and platelets, which play an important role in pro-
coagulant activity. It is thought that proinflamma-
tory cytokines increase the expression of molecules 
on the endothelial cells adhered to by parasitizing 1578 JASMINA POLUGA ET AL.
erythrocytes. Proinflammatory cytokines enhance 
the expression of tissue factor on the endothelial 
cells and monocytes, and by generating the occur-
rence of thrombin, a molecule with significant roles 
in cross-reactions of inflammation and coagulation 
(Clark et al., 2006). The speed, time and intensity 
of release of cytokines varies considerably in differ-
ent stages of the disease and between different in-
dividuals, thus forming a characteristic clinical fea-
ture. It is believed that proinflammatory cytokines 
are responsible for the occurrence of fever, nausea, 
vomiting,  diarrhea,  anorexia,  myalgia,  thrombo-
cytopenia, immunosuppression, coagulopathy and 
neurological manifestations (Jennings et al., 2006). 
In severe forms of malaria, the concentrations of 
proinflammatory cytokines, such as TNF-α, IL-1, 
IL-6, and IL-8, are elevated in the serum. The high 
level of TNF-α in patients with falciparum malaria 
correlates with the severity of the disease, with the 
appearance  of  hypoglycemia,  hyperparasitemia, 
jaundice, kidney damage, cardiovascular complica-
tions and death (Mordmüller et al., 2007).
The aim of this study was to determine the serum 
levels of TNF-α and interleukin-6, and to establish 
their correlation with other clinical and laboratory 
parameters. 
MATERIALS AND METHODS
The study included 34 patients with imported ma-
laria who were treated from 2007 to 2010 at the 
Clinic of Infectious and Tropical Diseases, Clinical 
Center of Serbia. From the total number of patients, 
27 (79.41%) had falciparum malaria, while only 7 
(20.59%) had malaria caused by the other type of 
plasmodium (vivax ovale). 
The  following  data  sources  were  used  in  this 
study: medical records, hematological, biochemical, 
parasitological and immunological analysis.
The most important parasitological analysis used 
in the study was the examination of thick and thin 
peripheral blood smears, stained with Giemsa. The 
level of parasitemia may be expressed either as a per-
centage of parasitized erythrocytes or as the number 
of parasites per microliter of blood. 
The  immunological  analyses  of  the  cytokines 
(TNF-α and IL-6) were performed at the Center for 
Medical Biochemistry, Clinical Center of Serbia, us-
ing the method of Quantikine ELISA Kit (R&D Sys-
tems).
The serum samples of patients for cytokine anal-
ysis were taken in two stages: immediately after the 
admission  and  at  the  end  of  antimalarial  therapy, 
when the parasitemia was negative. After centrifuga-
tion, they were separated and stored at -70˚C until 
use.
The method by which the cytokines were deter-
mined was the quantitative sandwich enzyme immu-
noassay technique. A monoclonal antibody specific 
for TNF-α/IL-6 was pre-coated onto a microplate. 
Standards and samples are pipetted into the wells and 
any TNF-α/IL-6 present was bound by the immo-
bilized antibody. After washing away any unbound 
substances,  an  enzyme-linked  polyclonal  antibody 
specific for TNF-α/IL-6 was added to the wells. Fol-
lowing a wash to remove any unbound antibody-
enzyme reagent, a substrate solution was added to 
the wells and color developed in proportion to the 
amount of TNF-α/IL-6 bound in the initial step. The 
color development was stopped and the intensity of 
the color was measured. 
The sensitivity (i.e. minimum detectable dose) of 
TNF-α was 1.6 pg/ml, and for IL-6, 0.70 pg /ml.
The following methods were used in statistical 
analysis: methods of descriptive statistics: mean val-
ue, standard deviation; Spearman’s rank correlation 
to determine the correlation between the levels of 
cytokines and the other clinical and laboratory pa-
rameters; analysis of variance (ANOVA) to compare 
the levels of TNF-α in patients with malaria in rela-
tion to the control values; Kolmogorov-Smirnov test 
and Mann-Whitney test were used to compare the 
levels of IL-6 in patients with malaria in relation to 
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Fig. 1. Correlation on TNF-a with IL-6, the age and laboratory parameters in the first phase (1)
Fig. 2. Correlation on IL-6 with TNF-a, the age and laboratory parameters in the first phase (1)1580 JASMINA POLUGA ET AL.
RESULTS
The study included 34 patients. The cytokines TNF-α 
and IL-6 were examined at two phases: immediately 
after the admission of patients (1) and at the end of 
antimalarial therapy, when the parasitemia was nega-
tive (2). 
Using the methods of statistical analysis (ANO-
VA,  Kolmogorov-Smirnov  and  Mann-Whitney 
test) we have proved the increased values of TNF-α 
(p=0.027) and IL-6 (p=0.006) in the first phase. 
The ANOVA test confirmed that there was no 
statistically  significant  difference  in  the  values  of 
TNF-α (p=0.974) and IL-6 (p=0.827) between the 
two phases, i.e. before and after treatment.
Additional laboratory parameters were also tak-
en in each phase to determine the correlation and 
for monitoring dynamics in relation to the values of 
cytokines.
The values of D-dimer and C-reactive protein 
(CRP) were increased in the first phase, while the 
values of antithrombin III (AT3) and lactates were in 
the reference range. 
In the second phase, there was a decrease in the 
value of laboratory parameters of the first phase, D-
dimer and CRP. The values of AT3 and lactates were 
increased, but within the reference range.
The results show that there is a very strong cor-
relation between TNF and IL-6 in the first phase. 
Increased TNF-α levels correlated with an older age, 
the level of parasitemia, as did the elevated values of 
procalcitonin, D-dimer and LDH, but also with the 
lower values of platelets, leukocytes, serum iron, AT3 
and Hb.
The increased values of IL-6 correlated with the 
level of parasitemia, elevated values of D-dimer and 
lactates.  A  negative  correlation  was  observed  for 
thrombocytopenia and leucopenia. Unlike the TNF-α, 
elevated values of IL-6 poorly correlated with age.   
The values of TNF-α in the second phase strong-
ly correlated with the number of platelets. The val-
ues of IL-6 in the second phase strongly correlated 
with the value of D-dimer. It was concluded that in 
the first phase, before starting treatment, TNF-α and 
IL-6 correlated more with the laboratory parameters 
of the same phase.
DISCUSSION
The role of cytokines in the pathogenesis of malar-
ia has been clearly confirmed, but not completely 
understood. It is thought that many factors impact 
on their level, which in the course of malaria de-
pends on the circadian rhythm, and in accordance 
with this, there are large variations in the serum 
cytokine levels. TNF-α appears to be the most im-
portant  in  the  early  immune  response  and  sub-
sequent  pathological  manifestations.  It  has  been 
proved that its concentration regulates the levels of 
the other cytokines as well, particularly in relation 
to IL-6 (Angulо and Fresno, 2002). Thus we could 
explain the results of this study, where the levels of 
TNF-α correlated to a high degree with other lab-
oratory parameters in relation to IL-6, especially 
when taking into account the parameters that in-
dicate the more difficult forms of disease (anemia, 
thrombocytopenia, high value of LDH). The results 
show a significant increase in TNF-α and IL-6 in 
the first phase, in the presence of parasitemia, and 
before the effects of antimalarial therapy. In addi-
tion, there is a very strong correlation between the 
levels of TNF-α and IL-6 in the first phase and their 
significant association with the level of parasitemia. 
Many other authors have also established their mu-
tual coordination and association with the degree 
of parasitemia in patients with malaria (Shaffer et 
al., 1991; McGuire et al., 1998; Zeyrek et al., 2006).
According to a study from Hamburg (Kern et al., 
1989), an increase in TNF-α and IL-6 was observed 
mainly in patients with falciparum malaria, while the 
concentrations of TNF-α and IL-6 correlated with the 
degree of parasitemia and the occurrence of compli-
cations. Thereby, they found a correlation between 
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poglycemia, hyperbilirubinemia and acute renal fail-
ure, which is consistent with the results of this study. 
A study from Pakistan showed almost identical re-
sults in falciparum malaria, but there was no cor-
relation with the degree of parasitemia (Gandapuр 
and Malik, 1996). Research conducted in Mali, in pa-
tients with falciparum malaria, showed a significant 
increase in cytokines in patients, including TNF-α 
and  IL-6,  but  the  correlation  between  hyperpara-
sitemia and anemia with increased concentrations of 
IL-6 has not been proven (Lyke et al., 2004). 
In  the  enlisted  patients,  increased  levels  of 
cytokines were in a stronger (TNF-α) or weaker 
(IL-6) correlation with the age. Authors from Pa-
kistan (Gandapuр and Malik, 1996) indicated that 
Table 1. The values     of cytokines in the first (1) and second (2) phase
Type of cytokines Mean value (pg/ml)  SD
 TNF-α  (1)    21.03  17.39
  IL-6  (1)    31.70  39.25
 TNF-α  (2)    5.17  3.59
  IL-6  (2)   7.46  6.32
 
Table 2. The values     of cytokines of the controls
 Type of cytokines Mean value (pg/ml)  SD
 TNF-α    5.73 2.38
  IL-6    3.92  2.19
Table 3. The values     of additional laboratory parameters (phase 1)
Laboratory parameters  Mean value SD
 D-dimer 765.36 917.01
 Antithrombin III (AT3) 85.55 18.01
 Lactates  1.33 0.61
 C-reactive protein (CRP) 114.41 84.88
Table 4. The values     of additional laboratory parameters (phase 2)
Laboratory parameters  Mean value SD
D-dimer 211.40 142.16
Antithrombin III (AT3) 100.32 13.76
Lactates   1.52 0.69
C-reactive protein (CRP) 49.43 116.03
Table 5. Correlation of TNF-α and IL-6 in the second phase (2)
Type of cytokines   Laboratory parameters R p
TNF-α   (2) Platelets (2) (**) -0.472 0,015
IL -6   (2) D-dimer  (2) (**) 0.531 0.0061582 JASMINA POLUGA ET AL.
the concentrations of TNF-α in children with fal-
ciparum  malaria  increased  with  age,  whereas  in 
adults there was no difference. Studies show that 
the concentrations of inflammatory mediators in 
serum/plasma, such as cytokines and acute phase 
proteins, increase with aging. The levels of circulat-
ing cytokines TNF-α and IL-6 are associated with 
morbidity and mortality in old age, and considered 
to cause or to exacerbate the risk factors in patho-
logical conditions related to the age (Bruunsgaard 
et al., 2001; Krabbe et al., 2004). It is thought that 
in a relatively healthy elderly population, increas-
ing  levels  of  circulating  IL-6  present  a  systemic 
response to local proinflammatory activity; how-
ever, when inflammatory diseases associated with 
old  age  progress,  the  level  of  circulating  TNF-α 
increases,  which  gradually  becomes  a  stronger 
marker of morbidity than IL-6 (Brüünsgaard and 
Pedersen, 2003). 
The increased levels of TNF-α and IL-6 correlate 
with thrombocytopenia and a high concentration of 
D-dimer in both phases, i.e. before and after treat-
ment, which is consistent with the pathophysiologi-
cal mechanisms that occur in the course of this dis-
ease. In fact, the activation of the coagulation system 
leads to the appearance of fibrin degradation prod-
ucts (FDP), i.e. D-dimer in the circulation, which we 
found in malaria as well, mainly in those caused by 
Plasmodium falciparum. Initiation of the coagulation 
cascade and fibrinolytic system is caused by parasi-
tized erythrocytes and/or activated platelets (Fran-
cischetti, 2008; Ghosh and Shetty, 2008). Parasitized 
erythrocytes  adhere  to  the  capillary  endothelium, 
causing  further  activation  which  results  in  plate-
let consumption and the activation of coagulation, 
which may culminate in the appearance of DIC (dis-
seminated  intravascular  coagulation).  IL-6  stimu-
lates platelets, which are manifested by an increased 
activation of thrombin and increased procoagulant 
activity,  and  coagulation  markers  detect  changes 
as a response to the effects of TNF-α (Esmon et al., 
1999). In the first phase, we found strong correlation 
between  TNF-α  and  AT3,  whose  values  are  often 
reduced in falciparum malaria, especially its severe 
forms.
These results are expected when we have in mind 
the pathophysiological mechanism in which cytokine 
production and parasitized erythrocytes cause the 
consumption of AT3  (Mohanty et al., 1997). In con-
trast to the correlation of TNF-α and AT3, in the first 
phase we registered a correlation between increased 
levels of IL-6 and the increase of lactates. Some au-
thors  also  find  an  association  between  increased 
concentrations of IL-6 and IL-10 and lactates, before 
starting antimalarial therapy (Day et al., 1999). 
Sarthou et al. (1997) have shown a decline in 
the concentrations of TNF-α and IL-6 after anti-
malarial treatment. According to the results of this 
study, the average values of TNF-α and IL-6 in the 
second phase were much lower than values before 
therapy, but the difference in values was not statis-
tically  significant.  The  time  interval  between  the 
determination  of  cytokine  concentrations  before 
and after treatment, i.e. during the presence or ab-
sence of parasitemia, was an average of 7 days, but 
for some patients this period was shorter. Specifi-
cally, these were patients who were taking antima-
larial therapy on their own initiative, and the time 
of treatment was shorter. Most probably, this is the 
reason for the observed disparities between the lev-
els of cytokines before and after treatment. Namely, 
after the therapy, they were generally reduced in all 
patients, albeit not equally.
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